Pharma, Biotech and Generics Industry News | The Pharmaletter
WEB11 September 2024 NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s
Pharmaceutical Industry News | The Pharmaletter
WEBSep 5, 2024 · California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD).
Special Reports - The Pharma Letter
WEBJun 17, 2020 · Non-alcoholic steatohepatitis (NASH), the most severe form of non-alcoholic fatty liver disease (NAFLD), has been generating grave concern throughout the medical community, writes Thomas Liquard, chief executive of Australian biopharma Immuron, in his overview of the race to market effective treatments for this condition which is our first quarterly Special Report of 2017.
Beaufour Ipsen: Paxeladine - Pharmaceutical industry news | The ...
WEBMay 14, 1995 · Subscribe Now. Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
UPJOHN RETIREMENT - Pharmaceutical industry news | The …
WEBApr 17, 1994 · Subscribe Now. Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
About The Pharma Letter | The Pharmaletter
WEB3 days ago · The Pharmaletter is a digital-only publication that covers the global pharmaceutical, biotech, generic and biosimilar industries. Founded in 1991, it offers news, analysis, data and trends on company, product, regulatory and market developments.
Validus Pharma gets rights to six Novartis drugs in USA
WEBNov 19, 2012 · USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired USs rights to six well-known product lines, patent protection on which has now expired, from the US subsidiary of …
Pharma and Biotechnology Events and Conferences | The …
WEBJul 31, 2024 · The European subsidiary of Japanese drugmaker Daiichi Sankyo announced its reinforced commitment to addressing key unmet needs and barriers in cardiovascular (CV) care, by shining a light on inequalities in treatment and outcomes experienced by various patient groups.
Pharma News and Insights Podcast | The Pharmaletter
WEBJul 17, 2023 · This week in The Pharma Letter Podcast, we are speaking with the chief executive of British drug development company Ellipses Pharma. 23 January 2024
ASCO Annual Meeting - The Pharmaletter
WEBMay 31, 2024 · The event is organized by by the American Society of Clinical Oncology (ASCO). This year's program will feature over 200 sessions complementing Dr. Lynn Schuchter’s Presidential theme The Art and Science of Cancer Care: From Comfort to Cure.